Delivery Order SPE2DB20D3103-SPE2DB22FL8G7
Award Date 12/1/21
Potential Completion Date 12/2/21
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Omnipaque 350 mg/ml infusion bottles (100 ml) to the Defense Logistics Agency (DLA). The contract, valued at $9,456.82, was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of September 2, 2022. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Omnipaque 350 mg/ml pluspak 500 ml, a pharmaceutical product, to the U.S. Defense Department's Medical Supply Chain (also known as the Defense Logistics Agency (DLA) Troop Support Medical) for $15,067.54. The contract is a firm-fixed price delivery order with an ultimate completion date of October 13, 2022. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,057.95 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML infusion bottles of 500ML. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, which runs through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,513.00 firm fixed-price delivery order is for the supply of Omnipaque 350 mg/mL infusion bottles. The contract has a completion date of July 25, 2023 and was awarded on July 24, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Omnipaque 350 mg/ml pharmaceutical products to the Defense Logistics Agency (DLA). The $2,513.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,984.20 firm fixed-price delivery order is for the supply of Omnipaque 350 mg/ml infusion bottles, a radiopaque contrast agent used in medical imaging procedures. The contract has a completion date of July 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,498.20, is for the delivery order of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract has a final completion date of February 1, 2024 and is a firm fixed-price delivery order. The award was made on January 31, 2024, and there is no set-aside designation for this contract. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 75ML. The $3,038.50 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., which also does business as AmerisourceBergen. This IDC with the DLA Troop Support Medical serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the delivery of Omnipaque 350 mg/ml pluspak 500 ml, a pharmaceutical product. The $1,049.46 firm fixed price delivery order has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corporation, a for-profit organization, serves as the prime contractor and holds an indefinite delivery contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical company Amerisourcebergen Corporation, is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML pharmaceutical products. The $3,498.20 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery...